nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—atopic dermatitis	0.495	1	CpDpCtD
Sumatriptan—SLCO1A2—Prednisolone—atopic dermatitis	0.0398	0.136	CbGbCtD
Sumatriptan—SLCO1A2—Hydrocortisone—atopic dermatitis	0.0377	0.129	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—atopic dermatitis	0.0376	0.128	CbGbCtD
Sumatriptan—ABCG2—Hydrocortisone—atopic dermatitis	0.0283	0.0965	CbGbCtD
Sumatriptan—ABCB1—Tacrolimus—atopic dermatitis	0.025	0.0855	CbGbCtD
Sumatriptan—SLCO1A2—Dexamethasone—atopic dermatitis	0.0234	0.0801	CbGbCtD
Sumatriptan—ABCB1—Loratadine—atopic dermatitis	0.0183	0.0626	CbGbCtD
Sumatriptan—ABCG2—Dexamethasone—atopic dermatitis	0.0176	0.06	CbGbCtD
Sumatriptan—ABCB1—Methylprednisolone—atopic dermatitis	0.0168	0.0572	CbGbCtD
Sumatriptan—ABCB1—Betamethasone—atopic dermatitis	0.0109	0.0372	CbGbCtD
Sumatriptan—ABCB1—Prednisolone—atopic dermatitis	0.0107	0.0367	CbGbCtD
Sumatriptan—ABCB1—Hydrocortisone—atopic dermatitis	0.0102	0.0348	CbGbCtD
Sumatriptan—ABCB1—Prednisone—atopic dermatitis	0.0101	0.0347	CbGbCtD
Sumatriptan—ABCB1—Dexamethasone—atopic dermatitis	0.00634	0.0216	CbGbCtD
Sumatriptan—Malaise—Triamcinolone—atopic dermatitis	4.7e-05	0.000248	CcSEcCtD
Sumatriptan—Anxiety—Hydrocortisone—atopic dermatitis	4.7e-05	0.000248	CcSEcCtD
Sumatriptan—Malaise—Methylprednisolone—atopic dermatitis	4.69e-05	0.000247	CcSEcCtD
Sumatriptan—Vertigo—Triamcinolone—atopic dermatitis	4.68e-05	0.000247	CcSEcCtD
Sumatriptan—Syncope—Triamcinolone—atopic dermatitis	4.68e-05	0.000246	CcSEcCtD
Sumatriptan—Vertigo—Methylprednisolone—atopic dermatitis	4.67e-05	0.000246	CcSEcCtD
Sumatriptan—Syncope—Methylprednisolone—atopic dermatitis	4.66e-05	0.000246	CcSEcCtD
Sumatriptan—Discomfort—Hydrocortisone—atopic dermatitis	4.66e-05	0.000245	CcSEcCtD
Sumatriptan—Connective tissue disorder—Prednisone—atopic dermatitis	4.65e-05	0.000245	CcSEcCtD
Sumatriptan—Oedema—Prednisolone—atopic dermatitis	4.63e-05	0.000244	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisolone—atopic dermatitis	4.63e-05	0.000244	CcSEcCtD
Sumatriptan—Vomiting—Tacrolimus—atopic dermatitis	4.61e-05	0.000243	CcSEcCtD
Sumatriptan—Loss of consciousness—Triamcinolone—atopic dermatitis	4.58e-05	0.000241	CcSEcCtD
Sumatriptan—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.57e-05	0.000241	CcSEcCtD
Sumatriptan—Rash—Tacrolimus—atopic dermatitis	4.57e-05	0.000241	CcSEcCtD
Sumatriptan—Dermatitis—Tacrolimus—atopic dermatitis	4.56e-05	0.00024	CcSEcCtD
Sumatriptan—Shock—Prednisolone—atopic dermatitis	4.55e-05	0.00024	CcSEcCtD
Sumatriptan—Cough—Triamcinolone—atopic dermatitis	4.55e-05	0.00024	CcSEcCtD
Sumatriptan—Headache—Tacrolimus—atopic dermatitis	4.54e-05	0.000239	CcSEcCtD
Sumatriptan—Oedema—Hydrocortisone—atopic dermatitis	4.52e-05	0.000238	CcSEcCtD
Sumatriptan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.52e-05	0.000238	CcSEcCtD
Sumatriptan—Convulsion—Triamcinolone—atopic dermatitis	4.52e-05	0.000238	CcSEcCtD
Sumatriptan—Tachycardia—Prednisolone—atopic dermatitis	4.52e-05	0.000238	CcSEcCtD
Sumatriptan—Convulsion—Methylprednisolone—atopic dermatitis	4.51e-05	0.000237	CcSEcCtD
Sumatriptan—Hypertension—Triamcinolone—atopic dermatitis	4.5e-05	0.000237	CcSEcCtD
Sumatriptan—Hypertension—Methylprednisolone—atopic dermatitis	4.49e-05	0.000237	CcSEcCtD
Sumatriptan—Infection—Hydrocortisone—atopic dermatitis	4.49e-05	0.000237	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisolone—atopic dermatitis	4.47e-05	0.000236	CcSEcCtD
Sumatriptan—Shock—Hydrocortisone—atopic dermatitis	4.45e-05	0.000234	CcSEcCtD
Sumatriptan—Myalgia—Triamcinolone—atopic dermatitis	4.44e-05	0.000234	CcSEcCtD
Sumatriptan—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.43e-05	0.000233	CcSEcCtD
Sumatriptan—Arthralgia—Methylprednisolone—atopic dermatitis	4.43e-05	0.000233	CcSEcCtD
Sumatriptan—Myalgia—Methylprednisolone—atopic dermatitis	4.43e-05	0.000233	CcSEcCtD
Sumatriptan—Eye disorder—Prednisone—atopic dermatitis	4.42e-05	0.000233	CcSEcCtD
Sumatriptan—Anxiety—Methylprednisolone—atopic dermatitis	4.41e-05	0.000233	CcSEcCtD
Sumatriptan—Tachycardia—Hydrocortisone—atopic dermatitis	4.41e-05	0.000232	CcSEcCtD
Sumatriptan—Flushing—Prednisone—atopic dermatitis	4.39e-05	0.000231	CcSEcCtD
Sumatriptan—Skin disorder—Hydrocortisone—atopic dermatitis	4.39e-05	0.000231	CcSEcCtD
Sumatriptan—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.39e-05	0.000231	CcSEcCtD
Sumatriptan—Ill-defined disorder—Betamethasone—atopic dermatitis	4.39e-05	0.000231	CcSEcCtD
Sumatriptan—Discomfort—Triamcinolone—atopic dermatitis	4.39e-05	0.000231	CcSEcCtD
Sumatriptan—Discomfort—Methylprednisolone—atopic dermatitis	4.38e-05	0.000231	CcSEcCtD
Sumatriptan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.37e-05	0.00023	CcSEcCtD
Sumatriptan—Dry mouth—Triamcinolone—atopic dermatitis	4.34e-05	0.000229	CcSEcCtD
Sumatriptan—Angioedema—Betamethasone—atopic dermatitis	4.32e-05	0.000228	CcSEcCtD
Sumatriptan—Angioedema—Dexamethasone—atopic dermatitis	4.32e-05	0.000228	CcSEcCtD
Sumatriptan—Nausea—Tacrolimus—atopic dermatitis	4.3e-05	0.000227	CcSEcCtD
Sumatriptan—Angiopathy—Prednisone—atopic dermatitis	4.29e-05	0.000226	CcSEcCtD
Sumatriptan—Confusional state—Methylprednisolone—atopic dermatitis	4.28e-05	0.000226	CcSEcCtD
Sumatriptan—Immune system disorder—Prednisone—atopic dermatitis	4.27e-05	0.000225	CcSEcCtD
Sumatriptan—Malaise—Betamethasone—atopic dermatitis	4.27e-05	0.000225	CcSEcCtD
Sumatriptan—Malaise—Dexamethasone—atopic dermatitis	4.27e-05	0.000225	CcSEcCtD
Sumatriptan—Oedema—Triamcinolone—atopic dermatitis	4.25e-05	0.000224	CcSEcCtD
Sumatriptan—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.25e-05	0.000224	CcSEcCtD
Sumatriptan—Vertigo—Dexamethasone—atopic dermatitis	4.25e-05	0.000224	CcSEcCtD
Sumatriptan—Vertigo—Betamethasone—atopic dermatitis	4.25e-05	0.000224	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.25e-05	0.000224	CcSEcCtD
Sumatriptan—Syncope—Dexamethasone—atopic dermatitis	4.24e-05	0.000224	CcSEcCtD
Sumatriptan—Syncope—Betamethasone—atopic dermatitis	4.24e-05	0.000224	CcSEcCtD
Sumatriptan—Arrhythmia—Prednisone—atopic dermatitis	4.23e-05	0.000223	CcSEcCtD
Sumatriptan—Infection—Triamcinolone—atopic dermatitis	4.23e-05	0.000223	CcSEcCtD
Sumatriptan—Hypotension—Hydrocortisone—atopic dermatitis	4.22e-05	0.000222	CcSEcCtD
Sumatriptan—Infection—Methylprednisolone—atopic dermatitis	4.22e-05	0.000222	CcSEcCtD
Sumatriptan—Shock—Triamcinolone—atopic dermatitis	4.19e-05	0.000221	CcSEcCtD
Sumatriptan—Shock—Methylprednisolone—atopic dermatitis	4.18e-05	0.00022	CcSEcCtD
Sumatriptan—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.16e-05	0.000219	CcSEcCtD
Sumatriptan—Loss of consciousness—Dexamethasone—atopic dermatitis	4.16e-05	0.000219	CcSEcCtD
Sumatriptan—Loss of consciousness—Betamethasone—atopic dermatitis	4.16e-05	0.000219	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisolone—atopic dermatitis	4.15e-05	0.000219	CcSEcCtD
Sumatriptan—Tachycardia—Triamcinolone—atopic dermatitis	4.15e-05	0.000219	CcSEcCtD
Sumatriptan—Tachycardia—Methylprednisolone—atopic dermatitis	4.14e-05	0.000218	CcSEcCtD
Sumatriptan—Skin disorder—Methylprednisolone—atopic dermatitis	4.12e-05	0.000217	CcSEcCtD
Sumatriptan—Erythema—Prednisone—atopic dermatitis	4.12e-05	0.000217	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.12e-05	0.000217	CcSEcCtD
Sumatriptan—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.11e-05	0.000217	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.1e-05	0.000216	CcSEcCtD
Sumatriptan—Convulsion—Dexamethasone—atopic dermatitis	4.1e-05	0.000216	CcSEcCtD
Sumatriptan—Convulsion—Betamethasone—atopic dermatitis	4.1e-05	0.000216	CcSEcCtD
Sumatriptan—Hypertension—Dexamethasone—atopic dermatitis	4.08e-05	0.000215	CcSEcCtD
Sumatriptan—Hypertension—Betamethasone—atopic dermatitis	4.08e-05	0.000215	CcSEcCtD
Sumatriptan—Paraesthesia—Hydrocortisone—atopic dermatitis	4.06e-05	0.000214	CcSEcCtD
Sumatriptan—Myalgia—Betamethasone—atopic dermatitis	4.03e-05	0.000212	CcSEcCtD
Sumatriptan—Myalgia—Dexamethasone—atopic dermatitis	4.03e-05	0.000212	CcSEcCtD
Sumatriptan—Anxiety—Betamethasone—atopic dermatitis	4.01e-05	0.000211	CcSEcCtD
Sumatriptan—Anxiety—Dexamethasone—atopic dermatitis	4.01e-05	0.000211	CcSEcCtD
Sumatriptan—Discomfort—Dexamethasone—atopic dermatitis	3.98e-05	0.00021	CcSEcCtD
Sumatriptan—Discomfort—Betamethasone—atopic dermatitis	3.98e-05	0.00021	CcSEcCtD
Sumatriptan—Hypotension—Methylprednisolone—atopic dermatitis	3.97e-05	0.000209	CcSEcCtD
Sumatriptan—Pain—Prednisolone—atopic dermatitis	3.96e-05	0.000208	CcSEcCtD
Sumatriptan—Decreased appetite—Hydrocortisone—atopic dermatitis	3.93e-05	0.000207	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.9e-05	0.000206	CcSEcCtD
Sumatriptan—Fatigue—Hydrocortisone—atopic dermatitis	3.9e-05	0.000205	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.88e-05	0.000204	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.87e-05	0.000204	CcSEcCtD
Sumatriptan—Pain—Hydrocortisone—atopic dermatitis	3.86e-05	0.000204	CcSEcCtD
Sumatriptan—Anaphylactic shock—Betamethasone—atopic dermatitis	3.86e-05	0.000203	CcSEcCtD
Sumatriptan—Oedema—Betamethasone—atopic dermatitis	3.86e-05	0.000203	CcSEcCtD
Sumatriptan—Oedema—Dexamethasone—atopic dermatitis	3.86e-05	0.000203	CcSEcCtD
Sumatriptan—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.86e-05	0.000203	CcSEcCtD
Sumatriptan—Infection—Dexamethasone—atopic dermatitis	3.84e-05	0.000202	CcSEcCtD
Sumatriptan—Infection—Betamethasone—atopic dermatitis	3.84e-05	0.000202	CcSEcCtD
Sumatriptan—Ill-defined disorder—Prednisone—atopic dermatitis	3.82e-05	0.000201	CcSEcCtD
Sumatriptan—Paraesthesia—Triamcinolone—atopic dermatitis	3.82e-05	0.000201	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisolone—atopic dermatitis	3.81e-05	0.000201	CcSEcCtD
Sumatriptan—Paraesthesia—Methylprednisolone—atopic dermatitis	3.81e-05	0.000201	CcSEcCtD
Sumatriptan—Anaemia—Prednisone—atopic dermatitis	3.81e-05	0.000201	CcSEcCtD
Sumatriptan—Shock—Dexamethasone—atopic dermatitis	3.8e-05	0.0002	CcSEcCtD
Sumatriptan—Shock—Betamethasone—atopic dermatitis	3.8e-05	0.0002	CcSEcCtD
Sumatriptan—Dyspnoea—Triamcinolone—atopic dermatitis	3.79e-05	0.0002	CcSEcCtD
Sumatriptan—Nervous system disorder—Dexamethasone—atopic dermatitis	3.79e-05	0.000199	CcSEcCtD
Sumatriptan—Nervous system disorder—Betamethasone—atopic dermatitis	3.79e-05	0.000199	CcSEcCtD
Sumatriptan—Agitation—Prednisone—atopic dermatitis	3.79e-05	0.000199	CcSEcCtD
Sumatriptan—Thrombocytopenia—Betamethasone—atopic dermatitis	3.78e-05	0.000199	CcSEcCtD
Sumatriptan—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.78e-05	0.000199	CcSEcCtD
Sumatriptan—Tachycardia—Betamethasone—atopic dermatitis	3.77e-05	0.000199	CcSEcCtD
Sumatriptan—Tachycardia—Dexamethasone—atopic dermatitis	3.77e-05	0.000199	CcSEcCtD
Sumatriptan—Angioedema—Prednisone—atopic dermatitis	3.76e-05	0.000198	CcSEcCtD
Sumatriptan—Hyperhidrosis—Betamethasone—atopic dermatitis	3.73e-05	0.000197	CcSEcCtD
Sumatriptan—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.73e-05	0.000197	CcSEcCtD
Sumatriptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.72e-05	0.000196	CcSEcCtD
Sumatriptan—Malaise—Prednisone—atopic dermatitis	3.72e-05	0.000196	CcSEcCtD
Sumatriptan—Vertigo—Prednisone—atopic dermatitis	3.7e-05	0.000195	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.7e-05	0.000195	CcSEcCtD
Sumatriptan—Syncope—Prednisone—atopic dermatitis	3.69e-05	0.000195	CcSEcCtD
Sumatriptan—Urticaria—Prednisolone—atopic dermatitis	3.68e-05	0.000194	CcSEcCtD
Sumatriptan—Fatigue—Triamcinolone—atopic dermatitis	3.67e-05	0.000193	CcSEcCtD
Sumatriptan—Fatigue—Methylprednisolone—atopic dermatitis	3.66e-05	0.000193	CcSEcCtD
Sumatriptan—Pain—Triamcinolone—atopic dermatitis	3.64e-05	0.000192	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisone—atopic dermatitis	3.62e-05	0.000191	CcSEcCtD
Sumatriptan—Hypotension—Dexamethasone—atopic dermatitis	3.61e-05	0.00019	CcSEcCtD
Sumatriptan—Hypotension—Betamethasone—atopic dermatitis	3.61e-05	0.00019	CcSEcCtD
Sumatriptan—Urticaria—Hydrocortisone—atopic dermatitis	3.59e-05	0.000189	CcSEcCtD
Sumatriptan—Body temperature increased—Hydrocortisone—atopic dermatitis	3.57e-05	0.000188	CcSEcCtD
Sumatriptan—Abdominal pain—Hydrocortisone—atopic dermatitis	3.57e-05	0.000188	CcSEcCtD
Sumatriptan—Convulsion—Prednisone—atopic dermatitis	3.57e-05	0.000188	CcSEcCtD
Sumatriptan—Hypertension—Prednisone—atopic dermatitis	3.56e-05	0.000187	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.52e-05	0.000185	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.52e-05	0.000185	CcSEcCtD
Sumatriptan—Myalgia—Prednisone—atopic dermatitis	3.51e-05	0.000185	CcSEcCtD
Sumatriptan—Arthralgia—Prednisone—atopic dermatitis	3.51e-05	0.000185	CcSEcCtD
Sumatriptan—Feeling abnormal—Triamcinolone—atopic dermatitis	3.51e-05	0.000185	CcSEcCtD
Sumatriptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.5e-05	0.000184	CcSEcCtD
Sumatriptan—Anxiety—Prednisone—atopic dermatitis	3.5e-05	0.000184	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.47e-05	0.000183	CcSEcCtD
Sumatriptan—Paraesthesia—Dexamethasone—atopic dermatitis	3.47e-05	0.000183	CcSEcCtD
Sumatriptan—Paraesthesia—Betamethasone—atopic dermatitis	3.47e-05	0.000183	CcSEcCtD
Sumatriptan—Discomfort—Prednisone—atopic dermatitis	3.47e-05	0.000183	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisolone—atopic dermatitis	3.41e-05	0.00018	CcSEcCtD
Sumatriptan—Urticaria—Triamcinolone—atopic dermatitis	3.38e-05	0.000178	CcSEcCtD
Sumatriptan—Urticaria—Methylprednisolone—atopic dermatitis	3.37e-05	0.000178	CcSEcCtD
Sumatriptan—Body temperature increased—Triamcinolone—atopic dermatitis	3.36e-05	0.000177	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisone—atopic dermatitis	3.36e-05	0.000177	CcSEcCtD
Sumatriptan—Oedema—Prednisone—atopic dermatitis	3.36e-05	0.000177	CcSEcCtD
Sumatriptan—Abdominal pain—Methylprednisolone—atopic dermatitis	3.36e-05	0.000177	CcSEcCtD
Sumatriptan—Decreased appetite—Dexamethasone—atopic dermatitis	3.36e-05	0.000177	CcSEcCtD
Sumatriptan—Decreased appetite—Betamethasone—atopic dermatitis	3.36e-05	0.000177	CcSEcCtD
Sumatriptan—Infection—Prednisone—atopic dermatitis	3.34e-05	0.000176	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.33e-05	0.000176	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.33e-05	0.000176	CcSEcCtD
Sumatriptan—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.33e-05	0.000175	CcSEcCtD
Sumatriptan—Fatigue—Betamethasone—atopic dermatitis	3.33e-05	0.000175	CcSEcCtD
Sumatriptan—Fatigue—Dexamethasone—atopic dermatitis	3.33e-05	0.000175	CcSEcCtD
Sumatriptan—Shock—Prednisone—atopic dermatitis	3.31e-05	0.000174	CcSEcCtD
Sumatriptan—Pain—Dexamethasone—atopic dermatitis	3.3e-05	0.000174	CcSEcCtD
Sumatriptan—Pain—Betamethasone—atopic dermatitis	3.3e-05	0.000174	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—atopic dermatitis	3.3e-05	0.000174	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—atopic dermatitis	3.28e-05	0.000173	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—atopic dermatitis	3.27e-05	0.000172	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—atopic dermatitis	3.25e-05	0.000171	CcSEcCtD
Sumatriptan—Asthenia—Hydrocortisone—atopic dermatitis	3.24e-05	0.000171	CcSEcCtD
Sumatriptan—Pruritus—Hydrocortisone—atopic dermatitis	3.2e-05	0.000168	CcSEcCtD
Sumatriptan—Feeling abnormal—Dexamethasone—atopic dermatitis	3.18e-05	0.000168	CcSEcCtD
Sumatriptan—Feeling abnormal—Betamethasone—atopic dermatitis	3.18e-05	0.000168	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.16e-05	0.000166	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.16e-05	0.000166	CcSEcCtD
Sumatriptan—Hypersensitivity—Triamcinolone—atopic dermatitis	3.13e-05	0.000165	CcSEcCtD
Sumatriptan—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.13e-05	0.000165	CcSEcCtD
Sumatriptan—Diarrhoea—Hydrocortisone—atopic dermatitis	3.09e-05	0.000163	CcSEcCtD
Sumatriptan—Urticaria—Dexamethasone—atopic dermatitis	3.07e-05	0.000162	CcSEcCtD
Sumatriptan—Urticaria—Betamethasone—atopic dermatitis	3.07e-05	0.000162	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.06e-05	0.000161	CcSEcCtD
Sumatriptan—Dizziness—Prednisolone—atopic dermatitis	3.06e-05	0.000161	CcSEcCtD
Sumatriptan—Asthenia—Triamcinolone—atopic dermatitis	3.05e-05	0.000161	CcSEcCtD
Sumatriptan—Abdominal pain—Dexamethasone—atopic dermatitis	3.05e-05	0.000161	CcSEcCtD
Sumatriptan—Abdominal pain—Betamethasone—atopic dermatitis	3.05e-05	0.000161	CcSEcCtD
Sumatriptan—Body temperature increased—Betamethasone—atopic dermatitis	3.05e-05	0.000161	CcSEcCtD
Sumatriptan—Body temperature increased—Dexamethasone—atopic dermatitis	3.05e-05	0.000161	CcSEcCtD
Sumatriptan—Asthenia—Methylprednisolone—atopic dermatitis	3.05e-05	0.00016	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—atopic dermatitis	3.02e-05	0.000159	CcSEcCtD
Sumatriptan—Pruritus—Triamcinolone—atopic dermatitis	3.01e-05	0.000159	CcSEcCtD
Sumatriptan—Pruritus—Methylprednisolone—atopic dermatitis	3e-05	0.000158	CcSEcCtD
Sumatriptan—Dizziness—Hydrocortisone—atopic dermatitis	2.99e-05	0.000157	CcSEcCtD
Sumatriptan—HTR1F—GPCR downstream signaling—CCL5—atopic dermatitis	2.98e-05	0.00134	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.97e-05	0.00133	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—CCR5—atopic dermatitis	2.97e-05	0.00133	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.97e-05	0.00133	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ADSL—atopic dermatitis	2.95e-05	0.00132	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	2.94e-05	0.00132	CbGpPWpGaD
Sumatriptan—Decreased appetite—Prednisone—atopic dermatitis	2.92e-05	0.000154	CcSEcCtD
Sumatriptan—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	2.92e-05	0.00131	CbGpPWpGaD
Sumatriptan—Rash—Prednisolone—atopic dermatitis	2.92e-05	0.000154	CcSEcCtD
Sumatriptan—Dermatitis—Prednisolone—atopic dermatitis	2.91e-05	0.000154	CcSEcCtD
Sumatriptan—Diarrhoea—Methylprednisolone—atopic dermatitis	2.9e-05	0.000153	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—atopic dermatitis	2.9e-05	0.000153	CcSEcCtD
Sumatriptan—Headache—Prednisolone—atopic dermatitis	2.9e-05	0.000153	CcSEcCtD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.9e-05	0.0013	CbGpPWpGaD
Sumatriptan—Constipation—Prednisone—atopic dermatitis	2.88e-05	0.000151	CcSEcCtD
Sumatriptan—Vomiting—Hydrocortisone—atopic dermatitis	2.87e-05	0.000151	CcSEcCtD
Sumatriptan—HTR1F—GPCR ligand binding—CXCL8—atopic dermatitis	2.87e-05	0.00129	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GLB1—atopic dermatitis	2.85e-05	0.00128	CbGpPWpGaD
Sumatriptan—Rash—Hydrocortisone—atopic dermatitis	2.85e-05	0.00015	CcSEcCtD
Sumatriptan—HTR1D—Signaling Pathways—CCL27—atopic dermatitis	2.85e-05	0.00128	CbGpPWpGaD
Sumatriptan—Dermatitis—Hydrocortisone—atopic dermatitis	2.85e-05	0.00015	CcSEcCtD
Sumatriptan—HTR1D—Signaling by GPCR—CCR3—atopic dermatitis	2.84e-05	0.00128	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL17—atopic dermatitis	2.83e-05	0.00127	CbGpPWpGaD
Sumatriptan—Headache—Hydrocortisone—atopic dermatitis	2.83e-05	0.000149	CcSEcCtD
Sumatriptan—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	2.82e-05	0.00126	CbGpPWpGaD
Sumatriptan—Dizziness—Triamcinolone—atopic dermatitis	2.81e-05	0.000148	CcSEcCtD
Sumatriptan—Dizziness—Methylprednisolone—atopic dermatitis	2.81e-05	0.000148	CcSEcCtD
Sumatriptan—ABCB1—Allograft Rejection—IL2—atopic dermatitis	2.81e-05	0.00126	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—NPS—atopic dermatitis	2.79e-05	0.00125	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—TAC1—atopic dermatitis	2.79e-05	0.00125	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	2.79e-05	0.00125	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	2.78e-05	0.00125	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	2.78e-05	0.00125	CbGpPWpGaD
Sumatriptan—Feeling abnormal—Prednisone—atopic dermatitis	2.77e-05	0.000146	CcSEcCtD
Sumatriptan—Asthenia—Dexamethasone—atopic dermatitis	2.77e-05	0.000146	CcSEcCtD
Sumatriptan—Asthenia—Betamethasone—atopic dermatitis	2.77e-05	0.000146	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—atopic dermatitis	2.75e-05	0.000145	CcSEcCtD
Sumatriptan—Nausea—Prednisolone—atopic dermatitis	2.75e-05	0.000145	CcSEcCtD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCR3—atopic dermatitis	2.73e-05	0.00123	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ADSL—atopic dermatitis	2.73e-05	0.00123	CbGpPWpGaD
Sumatriptan—Pruritus—Dexamethasone—atopic dermatitis	2.73e-05	0.000144	CcSEcCtD
Sumatriptan—Pruritus—Betamethasone—atopic dermatitis	2.73e-05	0.000144	CcSEcCtD
Sumatriptan—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	2.73e-05	0.00123	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	2.73e-05	0.00123	CbGpPWpGaD
Sumatriptan—Vomiting—Triamcinolone—atopic dermatitis	2.71e-05	0.000143	CcSEcCtD
Sumatriptan—HTR1F—Signaling by GPCR—CCL5—atopic dermatitis	2.7e-05	0.00121	CbGpPWpGaD
Sumatriptan—Vomiting—Methylprednisolone—atopic dermatitis	2.7e-05	0.000142	CcSEcCtD
Sumatriptan—Nausea—Hydrocortisone—atopic dermatitis	2.68e-05	0.000141	CcSEcCtD
Sumatriptan—Rash—Triamcinolone—atopic dermatitis	2.68e-05	0.000141	CcSEcCtD
Sumatriptan—HTR1F—GPCR downstream signaling—CCR5—atopic dermatitis	2.68e-05	0.0012	CbGpPWpGaD
Sumatriptan—Dermatitis—Triamcinolone—atopic dermatitis	2.68e-05	0.000141	CcSEcCtD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	2.68e-05	0.0012	CbGpPWpGaD
Sumatriptan—Rash—Methylprednisolone—atopic dermatitis	2.68e-05	0.000141	CcSEcCtD
Sumatriptan—Dermatitis—Methylprednisolone—atopic dermatitis	2.67e-05	0.000141	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—atopic dermatitis	2.67e-05	0.000141	CcSEcCtD
Sumatriptan—Headache—Triamcinolone—atopic dermatitis	2.67e-05	0.00014	CcSEcCtD
Sumatriptan—Headache—Methylprednisolone—atopic dermatitis	2.66e-05	0.00014	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—atopic dermatitis	2.66e-05	0.00014	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—atopic dermatitis	2.66e-05	0.00014	CcSEcCtD
Sumatriptan—Diarrhoea—Betamethasone—atopic dermatitis	2.64e-05	0.000139	CcSEcCtD
Sumatriptan—Diarrhoea—Dexamethasone—atopic dermatitis	2.64e-05	0.000139	CcSEcCtD
Sumatriptan—SLCO1B1—Metabolism—GLB1—atopic dermatitis	2.63e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCR3—atopic dermatitis	2.62e-05	0.00118	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.61e-05	0.00117	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	2.6e-05	0.00117	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL5—atopic dermatitis	2.59e-05	0.00116	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.57e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	2.56e-05	0.00115	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CXCL10—atopic dermatitis	2.56e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL17—atopic dermatitis	2.55e-05	0.00115	CbGpPWpGaD
Sumatriptan—Dizziness—Dexamethasone—atopic dermatitis	2.55e-05	0.000135	CcSEcCtD
Sumatriptan—Dizziness—Betamethasone—atopic dermatitis	2.55e-05	0.000135	CcSEcCtD
Sumatriptan—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	2.54e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TAC1—atopic dermatitis	2.53e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—NPS—atopic dermatitis	2.53e-05	0.00114	CbGpPWpGaD
Sumatriptan—Nausea—Triamcinolone—atopic dermatitis	2.53e-05	0.000133	CcSEcCtD
Sumatriptan—SLCO1B1—Metabolism—ADSL—atopic dermatitis	2.52e-05	0.00113	CbGpPWpGaD
Sumatriptan—Nausea—Methylprednisolone—atopic dermatitis	2.52e-05	0.000133	CcSEcCtD
Sumatriptan—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	2.51e-05	0.00113	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	2.5e-05	0.00112	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCR3—atopic dermatitis	2.48e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	2.48e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	2.48e-05	0.00111	CbGpPWpGaD
Sumatriptan—Hypersensitivity—Prednisone—atopic dermatitis	2.48e-05	0.000131	CcSEcCtD
Sumatriptan—Vomiting—Dexamethasone—atopic dermatitis	2.45e-05	0.000129	CcSEcCtD
Sumatriptan—Vomiting—Betamethasone—atopic dermatitis	2.45e-05	0.000129	CcSEcCtD
Sumatriptan—ABCG2—Metabolism—GLB1—atopic dermatitis	2.44e-05	0.00109	CbGpPWpGaD
Sumatriptan—Rash—Dexamethasone—atopic dermatitis	2.43e-05	0.000128	CcSEcCtD
Sumatriptan—Rash—Betamethasone—atopic dermatitis	2.43e-05	0.000128	CcSEcCtD
Sumatriptan—HTR1F—Signaling by GPCR—CCR5—atopic dermatitis	2.43e-05	0.00109	CbGpPWpGaD
Sumatriptan—Dermatitis—Betamethasone—atopic dermatitis	2.43e-05	0.000128	CcSEcCtD
Sumatriptan—Dermatitis—Dexamethasone—atopic dermatitis	2.43e-05	0.000128	CcSEcCtD
Sumatriptan—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	2.43e-05	0.00109	CbGpPWpGaD
Sumatriptan—Headache—Betamethasone—atopic dermatitis	2.42e-05	0.000127	CcSEcCtD
Sumatriptan—Headache—Dexamethasone—atopic dermatitis	2.42e-05	0.000127	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—atopic dermatitis	2.41e-05	0.000127	CcSEcCtD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.41e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	2.38e-05	0.00107	CbGpPWpGaD
Sumatriptan—Pruritus—Prednisone—atopic dermatitis	2.38e-05	0.000125	CcSEcCtD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.36e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	2.35e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NPS—atopic dermatitis	2.34e-05	0.00105	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TAC1—atopic dermatitis	2.34e-05	0.00105	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ADSL—atopic dermatitis	2.34e-05	0.00105	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	2.33e-05	0.00105	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	2.3e-05	0.00103	CbGpPWpGaD
Sumatriptan—Diarrhoea—Prednisone—atopic dermatitis	2.3e-05	0.000121	CcSEcCtD
Sumatriptan—HTR1F—Signaling Pathways—CXCR3—atopic dermatitis	2.29e-05	0.00103	CbGpPWpGaD
Sumatriptan—Nausea—Betamethasone—atopic dermatitis	2.29e-05	0.000121	CcSEcCtD
Sumatriptan—Nausea—Dexamethasone—atopic dermatitis	2.29e-05	0.000121	CcSEcCtD
Sumatriptan—DRD2—Signaling by GPCR—CCL11—atopic dermatitis	2.28e-05	0.00102	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	2.28e-05	0.00102	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	2.26e-05	0.00102	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.26e-05	0.00101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FCER2—atopic dermatitis	2.25e-05	0.00101	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.24e-05	0.00101	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	2.23e-05	0.001	CbGpPWpGaD
Sumatriptan—Dizziness—Prednisone—atopic dermatitis	2.22e-05	0.000117	CcSEcCtD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	2.21e-05	0.000992	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CCL5—atopic dermatitis	2.2e-05	0.00099	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.18e-05	0.00098	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL5—atopic dermatitis	2.17e-05	0.000976	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	2.16e-05	0.000972	CbGpPWpGaD
Sumatriptan—Vomiting—Prednisone—atopic dermatitis	2.14e-05	0.000113	CcSEcCtD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.13e-05	0.000957	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	2.12e-05	0.000954	CbGpPWpGaD
Sumatriptan—Rash—Prednisone—atopic dermatitis	2.12e-05	0.000112	CcSEcCtD
Sumatriptan—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	2.12e-05	0.000951	CbGpPWpGaD
Sumatriptan—Dermatitis—Prednisone—atopic dermatitis	2.12e-05	0.000112	CcSEcCtD
Sumatriptan—Headache—Prednisone—atopic dermatitis	2.11e-05	0.000111	CcSEcCtD
Sumatriptan—DRD2—Signaling Pathways—CCL22—atopic dermatitis	2.09e-05	0.000939	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	2.08e-05	0.000934	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	2.08e-05	0.000934	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.07e-05	0.00093	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	2.06e-05	0.000924	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	2.06e-05	0.000924	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCR3—atopic dermatitis	2.05e-05	0.00092	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.04e-05	0.000918	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	2.04e-05	0.000916	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.03e-05	0.000912	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	2.02e-05	0.000905	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	2.02e-05	0.000905	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	2.01e-05	0.000901	CbGpPWpGaD
Sumatriptan—Nausea—Prednisone—atopic dermatitis	2e-05	0.000105	CcSEcCtD
Sumatriptan—DRD2—GPCR ligand binding—CCR5—atopic dermatitis	1.99e-05	0.000892	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.98e-05	0.000891	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—MAPK8—atopic dermatitis	1.98e-05	0.000888	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	1.97e-05	0.000882	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	1.94e-05	0.000869	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	1.93e-05	0.000868	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.92e-05	0.000861	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	1.91e-05	0.000855	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	1.9e-05	0.000854	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	1.9e-05	0.000851	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	1.89e-05	0.000848	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	1.89e-05	0.000848	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.88e-05	0.000846	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL27—atopic dermatitis	1.86e-05	0.000837	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	1.86e-05	0.000836	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR3—atopic dermatitis	1.86e-05	0.000835	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL10—atopic dermatitis	1.85e-05	0.000832	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	1.85e-05	0.000832	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	1.83e-05	0.000823	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.83e-05	0.000823	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TAC1—atopic dermatitis	1.83e-05	0.00082	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—NPS—atopic dermatitis	1.83e-05	0.00082	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.82e-05	0.000818	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.8e-05	0.000806	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	1.8e-05	0.000806	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCR3—atopic dermatitis	1.79e-05	0.000804	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.76e-05	0.000791	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	1.76e-05	0.000788	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	1.73e-05	0.000776	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	1.71e-05	0.00077	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	1.7e-05	0.000762	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL5—atopic dermatitis	1.7e-05	0.000762	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	1.69e-05	0.00076	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.69e-05	0.000758	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	1.68e-05	0.000754	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	1.68e-05	0.000754	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL17—atopic dermatitis	1.67e-05	0.000751	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—NPS—atopic dermatitis	1.66e-05	0.000745	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TAC1—atopic dermatitis	1.66e-05	0.000745	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.65e-05	0.00074	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	1.64e-05	0.000738	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCR3—atopic dermatitis	1.63e-05	0.00073	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CXCL8—atopic dermatitis	1.62e-05	0.000728	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCL5—atopic dermatitis	1.6e-05	0.000717	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.58e-05	0.000708	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	1.56e-05	0.000699	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—IL2—atopic dermatitis	1.55e-05	0.000695	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL5—atopic dermatitis	1.54e-05	0.000692	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	1.54e-05	0.000689	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	1.54e-05	0.000689	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	1.52e-05	0.000684	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	1.5e-05	0.000672	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	1.5e-05	0.000672	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NPS—atopic dermatitis	1.5e-05	0.000672	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	1.49e-05	0.000669	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NGF—atopic dermatitis	1.48e-05	0.000664	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CXCL8—atopic dermatitis	1.47e-05	0.000661	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	1.47e-05	0.000659	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	1.46e-05	0.000658	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NPS—atopic dermatitis	1.46e-05	0.000658	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.45e-05	0.00065	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	1.44e-05	0.000648	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCR5—atopic dermatitis	1.44e-05	0.000646	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	1.44e-05	0.000645	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	1.42e-05	0.000637	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL2—atopic dermatitis	1.41e-05	0.000631	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL5—atopic dermatitis	1.39e-05	0.000624	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	1.37e-05	0.000614	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL5—atopic dermatitis	1.36e-05	0.000611	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL11—atopic dermatitis	1.35e-05	0.000605	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CMA1—atopic dermatitis	1.35e-05	0.000605	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GLB1—atopic dermatitis	1.32e-05	0.000591	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	1.31e-05	0.00059	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	1.29e-05	0.000579	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	1.28e-05	0.000574	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.27e-05	0.000572	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT6—atopic dermatitis	1.27e-05	0.000569	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADSL—atopic dermatitis	1.26e-05	0.000567	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	1.26e-05	0.000567	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	1.25e-05	0.000562	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	1.25e-05	0.000559	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NFKBIA—atopic dermatitis	1.22e-05	0.000547	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	1.2e-05	0.000539	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	1.19e-05	0.000532	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	1.16e-05	0.000521	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	1.16e-05	0.000521	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	1.13e-05	0.000508	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	1.12e-05	0.000504	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.12e-05	0.000501	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.12e-05	0.000501	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR3—atopic dermatitis	1.1e-05	0.000493	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.09e-05	0.000491	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.04e-05	0.000466	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.04e-05	0.000465	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.02e-05	0.000458	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.02e-05	0.000458	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.01e-05	0.000456	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.01e-05	0.000453	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	9.99e-06	0.000449	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PPARA—atopic dermatitis	9.98e-06	0.000448	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	9.9e-06	0.000445	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NPS—atopic dermatitis	9.8e-06	0.00044	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TAC1—atopic dermatitis	9.8e-06	0.00044	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	9.7e-06	0.000435	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	9.61e-06	0.000431	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NGF—atopic dermatitis	9.45e-06	0.000424	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	9.41e-06	0.000423	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NGF—atopic dermatitis	9.26e-06	0.000416	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARA—atopic dermatitis	9.25e-06	0.000415	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	9.21e-06	0.000414	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	9.2e-06	0.000413	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.13e-06	0.00041	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL5—atopic dermatitis	9.11e-06	0.000409	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	9e-06	0.000404	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	8.99e-06	0.000404	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	8.84e-06	0.000397	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	8.81e-06	0.000395	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	8.69e-06	0.00039	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARA—atopic dermatitis	8.54e-06	0.000383	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2—atopic dermatitis	8.31e-06	0.000373	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	8.27e-06	0.000371	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARA—atopic dermatitis	7.91e-06	0.000355	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	7.8e-06	0.00035	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	7.77e-06	0.000349	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.73e-06	0.000347	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	7.65e-06	0.000343	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	7.63e-06	0.000343	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	7.61e-06	0.000342	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	7.39e-06	0.000332	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NGF—atopic dermatitis	7.05e-06	0.000317	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	7.02e-06	0.000315	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	6.86e-06	0.000308	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	6.79e-06	0.000305	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	6.71e-06	0.000301	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL5—atopic dermatitis	6.68e-06	0.0003	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	6.49e-06	0.000291	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NGF—atopic dermatitis	6.19e-06	0.000278	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	6.16e-06	0.000277	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR5—atopic dermatitis	6.02e-06	0.00027	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—atopic dermatitis	5.89e-06	0.000264	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.81e-06	0.000261	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	5.56e-06	0.00025	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	5.44e-06	0.000244	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—atopic dermatitis	5.31e-06	0.000239	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	5.29e-06	0.000237	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—atopic dermatitis	5.2e-06	0.000234	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	5.18e-06	0.000232	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	5.11e-06	0.000229	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	4.89e-06	0.00022	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—atopic dermatitis	4.88e-06	0.000219	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	4.79e-06	0.000215	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARA—atopic dermatitis	4.27e-06	0.000192	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	4.15e-06	0.000186	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—atopic dermatitis	3.96e-06	0.000178	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	3.94e-06	0.000177	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	3.65e-06	0.000164	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	3.64e-06	0.000163	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—atopic dermatitis	3.48e-06	0.000156	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—atopic dermatitis	3.46e-06	0.000155	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	3.2e-06	0.000144	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—atopic dermatitis	3.12e-06	0.00014	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—atopic dermatitis	3.06e-06	0.000137	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.33e-06	0.000105	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.05e-06	9.18e-05	CbGpPWpGaD
